Alector Ownership

ALEC Stock  USD 2.55  0.02  0.78%   
Alector holds a total of 97.93 Million outstanding shares. The majority of Alector outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alector to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alector. Please pay attention to any change in the institutional holdings of Alector as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2017-12-31
Previous Quarter
96.7 M
Current Value
96.7 M
Avarage Shares Outstanding
75.3 M
Quarterly Volatility
14.3 M
 
Covid
Some institutional investors establish a significant position in stocks such as Alector in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Alector, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to -73.48. As of November 29, 2024, Common Stock Shares Outstanding is expected to decline to about 76.6 M. In addition to that, Net Loss is expected to decline to about (126 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alector. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Alector Stock refer to our How to Trade Alector Stock guide.

Alector Stock Ownership Analysis

About 86.0% of the company shares are held by institutions such as insurance companies. The book value of Alector was presently reported as 1.21. The company has Price/Earnings To Growth (PEG) ratio of 0.45. Alector recorded a loss per share of 1.71. The entity had not issued any dividends in recent years. Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. The company was founded in 2013 and is headquartered in South San Francisco, California. Alector operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 269 people. For more info on Alector please contact Arnon Rosenthal at 415 231 5660 or go to https://www.alector.com.
Besides selling stocks to institutional investors, Alector also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Alector's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Alector's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Alector Quarterly Liabilities And Stockholders Equity

516.02 Million

Alector Insider Trades History

About 10.0% of Alector are currently held by insiders. Unlike Alector's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Alector's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Alector's insider trades
 
Covid

Alector Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Alector is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alector backward and forwards among themselves. Alector's institutional investor refers to the entity that pools money to purchase Alector's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Euclidean Capital Llc2024-09-30
1.3 M
Deerfield Management Co2024-09-30
1.1 M
Jacobs Levy Equity Management, Inc.2024-09-30
M
Franklin Resources Inc2024-09-30
963.5 K
Baker Bros Advisors Lp2024-09-30
927.3 K
Dafna Capital Management Llc2024-09-30
912.9 K
T. Rowe Price Associates, Inc.2024-06-30
869.6 K
Alliancebernstein L.p.2024-06-30
767 K
Charles Schwab Investment Management Inc2024-09-30
760.6 K
Fmr Inc2024-09-30
14.6 M
Blackrock Inc2024-06-30
9.1 M
Note, although Alector's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Alector Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Alector insiders, such as employees or executives, is commonly permitted as long as it does not rely on Alector's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Alector insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Alector Outstanding Bonds

Alector issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Alector uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Alector bonds can be classified according to their maturity, which is the date when Alector has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Alector Corporate Filings

8K
25th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
12th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
10th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
25th of April 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Alector offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alector's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alector Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alector Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alector. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Alector Stock refer to our How to Trade Alector Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alector. If investors know Alector will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alector listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.86)
Earnings Share
(1.71)
Revenue Per Share
0.661
Quarterly Revenue Growth
0.684
Return On Assets
(0.19)
The market value of Alector is measured differently than its book value, which is the value of Alector that is recorded on the company's balance sheet. Investors also form their own opinion of Alector's value that differs from its market value or its book value, called intrinsic value, which is Alector's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alector's market value can be influenced by many factors that don't directly affect Alector's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alector's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alector is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alector's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.